RDD Japan secretariat/ASrid cooperated with the RDD Press Seminar organized by Pfizer Inc. from the planning stage as the secretariat of the RDD Japan. In addition, Yukiko Nishimura, President of ASrid, gave a lecture.

Date: February 16, 2021

Program

Lecture 1: Current status of treatment development for muscular dystrophy, with special focus on DMD

Dr. Harumasa Nakamura, Director, Clinical Research Support Division, National Center of Neurology and Psychiatry

Lecture 2: Confronting the disease and shining a light on it - A positive attitude even under the severe circumstances of the new corona

Patient of Duchenne Muscular Dystrophy

Lecture 3: Thoughts on "Equity" for rare and incurable diseases

Yukiko Nishimura, Executive Director, RDD Japan Secretariat

Closing Remarks by Dr. Fumi Yokoyama, General Manager, Rare Diseases Division, Pfizer Japan Inc.